Tranche Update on Edan Instruments, Inc.'s Equity Buyback Plan announced on February 9, 2021.
October 11, 2021 at 12:00 pm EDT
Share
From July 1, 2021 to September 30, 2021, the company has repurchased 1,545,400 shares, representing 0.27% for CNY 20.01 million. With this, the company has completed the repurchase of 2,126,600 shares, representing 0.37% for CNY 30 million under the buyback announced on February 9, 2021.
Edan Instruments, Inc. is a China-based company principally engaged in the research, development, manufacture, sales of medical electronic equipment products and in-vitro diagnostic products, as well as the provision of related services. The Company provides maternity product series, including doppler fetal heart beat monitors, ultrasonic doppler fetal heart beat monitors, fetal/maternal monitors and maternity integrated diagnostic monitoring systems; electrocardiograph series, including digital twelve-channel electrocardiographs, digital six-channel electrocardiographs, electrocardiographic workstations, single-channel electrocardiographs and multi-channel electrocardiographs; monitoring product series, including portable multi-variable monitors, central monitoring systems and oximeters, as well as ultrasonic image product series, including digital ultrasonic diagnostic systems and others. The Company is also involved in the spare parts sale and in vitro diagnostics products business.
EDAN INSTRUMENTS, INC. 